Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04896320
Title Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (2019-101826)
Acronym 2019-101826
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Providence Health & Services
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Providence Cancer Institute - Clackamas Clinic Clackamas Oregon 97015 United States Details
Providence Newberg Medical Center Newberg Oregon 97132 United States Details
Portland Providence Medical Center Portland Oregon 97213 United States Details
Providence St. Vincent Medical Center Portland Oregon 97225 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field